Date of response: 24 July 2026

Outcome: Information not disclosed

Category: Medicines Optimisation

Request

Guidelines for the treatment of Immune thrombocytopenia (ITP)

ICB Response

NN ICB 26 1682 Response Letter Final

pdf (194K)

Close
Search